Clinical trials
Phase 2 Epstein-Barr Virus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 5 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Cell Medica Ltd | 2 |
| Assuntina Sacco, M.D. | 1 |
| Baylor College of Medicine | 1 |
| Celgene | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Dana-Farber Cancer Institute | 1 |
| Massachusetts General Hospital | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| New York Medical College | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epstein-Barr Virus Infections | 18 |
| Nasopharyngeal Carcinoma | 4 |
| Lymphoproliferative Disorders | 3 |
| Nasopharyngeal Neoplasms | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Cytomegalovirus Infections | 2 |
| Hodgkin Disease | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| AIDS-Related Opportunistic Infections | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.